Literature DB >> 33636092

Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.

Ryan C Perkins1,2, Jaclyn Davis1, Andrew NeSmith3, Julianna Bailey4, Michael R Powers5, Nauman Chaudary6, Christopher Siracusa7, Ahmet Uluer1,8, George M Solomon9, Gregory S Sawicki1.   

Abstract

Entities:  

Year:  2021        PMID： 33636092     DOI： 10.1513/AnnalsATS.202012-1484RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  16 in total

1.  Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.

Authors:  Thida Ong; Frankline M Onchiri; Maria T Britto; Sonya L Heltshe; Larry G Kessler; Michael Seid; Bonnie W Ramsey
Journal:  J Cyst Fibros       Date:  2021-08-26       Impact factor: 5.482

2.  Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19.

Authors:  Davis Jaclyn; NeSmith Andrew; Perkins Ryan; Bailey Julianna; Siracusa Christopher; Chaudary Nauman; M Powers; Sawicki Gregory S; Solomon George M
Journal:  J Cyst Fibros       Date:  2021-03-26       Impact factor: 5.527

3.  Patient and Provider Experience With Cystic Fibrosis Telemedicine Clinic.

Authors:  Kalen Hendra; Fatima Neemuchwala; Marilynn Chan; Ngoc P Ly; Elizabeth R Gibb
Journal:  Front Pediatr       Date:  2021-11-24       Impact factor: 3.418

4.  Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic.

Authors:  George M Solomon; Julianna Bailey; James Lawlor; Peter Scalia; Gregory S Sawicki; Christopher Dowd; Kathryn A Sabadosa; Aricca Van Citters
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

5.  Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members.

Authors:  Aricca D Van Citters; Olivia Dieni; Peter Scalia; Christopher Dowd; Kathryn A Sabadosa; Jill D Fliege; Manu Jain; Robert W Miller; Clement L Ren
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

6.  Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future.

Authors:  Gregory S Sawicki; Aricca D Van Citters; Olivia Dieni; Kathryn A Sabadosa; Anne Willis; Debbie Benitez; Thida Ong; Elliott C Dasenbrook
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

7.  Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic.

Authors:  Christopher Dowd; Aricca D Van Citters; Olivia Dieni; Anne Willis; Leslie Powell; Kathryn A Sabadosa
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

8.  Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.

Authors:  Alex H Gifford; Thida Ong; Christopher Dowd; Aricca D Van Citters; Peter Scalia; Kathryn A Sabadosa; Gregory S Sawicki
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

9.  Cystic Fibrosis Respiratory Microbiology Monitoring during a Global Pandemic: Lessons Learned from a Shift to Telehealth.

Authors:  Alessandro N Franciosi; Pearce G Wilcox; Bradley S Quon
Journal:  Ann Am Thorac Soc       Date:  2022-03

10.  TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary).

Authors:  Alessandro N Franciosi; Bradley S Quon
Journal:  J Cyst Fibros       Date:  2021-09-08       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.